Gerard van Grinsven has resigned as president and CEO of Cancer
Treatment Centers of America “to pursue other interests.”
Van Grinsven will be replaced on an
interim basis by COO Steve Mackin and Anne Meisner, CEO of the company's
facility in Newnan, Ga. The Boca Raton, Fla.-based for-profit company
operates five cancer hospitals in Arizona, Georgia, Illinois, Oklahoma
and Pennsylvania.
Before joining Cancer Treatment Centers of
America in 2013, van Grinsven was president and CEO of Henry Ford West
Bloomfield (Mich.) Hospital. He started at Henry Ford in 2006 to oversee
the launch of the hospital, which opened in 2009.
Before Henry Ford, van Grinsven worked in the hotel industry,
including a stint as VP and area general manager for the Ritz-Carlton
Hotel Co.'s properties in Dearborn, Mich., Cleveland, St. Louis and
Philadelphia.
A Modern Healthcare investigation last year found
that three of the company's facilities were among the nation's leaders
in receiving Medicare supplemental “outlier” payments, which are
intended to compensate hospitals for unusually expensive episodes of
care. The payments are derived in part from hospitals' retail prices,
which typically exceed the actual cost of care.
The company has
also been criticized for broadcasting commercials that promote false
hope and cherry-picking patients to skew its outcomes. Van Grinsven
acknowledged in a Modern Healthcare Q&A that the company's patient
population “may not mirror the general population of cancer patients for
various reasons.”
This site is for information on the various Chemo treatments and Stem Cell Therapies since 1992. This journey became bitter sweet in 2014, with the passing of my beautiful and dear wife. Sherry, had fought Non - Hodgkins Lymphoma(NHL) since 1990, in and out of remissions time and time again. From T-Cell therapies(1990's) to Dual Cord Blood Transplant(2014), she was in Clinical Trials over the years. This site is for informational purpose only and is not to promote the use of certain therapies.
No comments:
Post a Comment